Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...

Etavopivat improved hemoglobin levels and reduced pain crises in a Phase 3 sickle cell disease trial, supporting potential ...

Newly diagnosed with DVT and a pulmonary embolism, columnist Michelle Harlan finds herself in an unfamiliar relationship with ...

People with sickle cell disease in Africa are less likely to use common treatments and may report lower burden, a global ...

The isolation of chronic disease isn't just about being physically alone; it's also emotional and social, says columnist ...

Bias in sickle cell care may be tied to opioid stigma, with patients more often described negatively in medical records, a ...

Having a remote job has been a game-changer for me as someone with sickle cell disease. I’m better able to manage my health — no rushed mornings, cold commutes, or physical strain. I can plan my day ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Children with sickle cell anemia (SCA), the most common and ...

Beam Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to approve ristoglogene autogetemcel, or risto-cel, its single-dose, gene-edited cell therapy candidate for people with ...

Agios Pharmaceuticals is planning to file an application with the U.S. Food and Drug Administration (FDA) in the coming months that will seek accelerated approval of its oral therapy mitapivat for ...